Novo Nordisk's pricing techniques within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of selling price gouging, pointing out the stark distinction amongst U.S. charges and people in Europe and copyright. Include these bits and pieces